Dr. Reddy's Laboratories Limited — Others, 18-11-2024: News Verification

Dr. Reddy's Laboratories has clarified a recent news article regarding a voluntary recall of two lots of Morphine Sulfate Extended-Release Tablets in the U.S., undertaken out of caution. The company does not assess this event as material under SEBI regulations and indicates it has no significant impact on operations or financial health. This proactive measure might enhance investor confidence in the company’s commitment to quality and safety. Investors could view this as a positive outlook, reflecting responsible management despite the recall's occurrence.